All posts by Chris Brooker
-
Chris Brooker | 15/05/2018
What happened after 1 Feb 2018?
Inspectors have been routinely asking pharmacists about abuse or threats arising from the rescheduling… here’s what they found...
-
Chris Brooker | 08/05/2018
Medicine supply under threat
Guild backs NPSA and calls for PBS listing of medicines to be conditional on supply through CSO wholesalers...
-
Chris Brooker | 13/03/2018
Pain MedsCheck delayed
Delays to new MedsCheck “disappointing” but revised start date expected soon, Guild says The new pharmacy Pain MedsCheck...
-
Chris Brooker | 06/02/2018
No change to ibuprofen
Application to reduce Schedule 2 ibuprofen pack sizes knocked back An application to reduce the size of S2...
-
Chris Brooker | 30/01/2018
AD pharmacists honoured
Three pharmacists have been recognised in the 2018 Australia Day honours list All three, including a PSA foundation...
-
Chris Brooker | 10/11/2017
‘Dark particles’ prompt recall
Apotex has announced that, in consultation with the TGA, it is recalling three batches of Apo-Perindopril Arginine 2.5...
-
Chris Brooker | 09/11/2017
Codeine: a done deal
Upscheduling to go ahead on 1 February, after TGA didn’t receive any formal submission to delay, senior bureaucrat...
-
Chris Brooker | 25/10/2017
Government tactics a ‘disgrace’
Amendments to allow easier importing of medicinal cannabis go before Parliament as government tactics described as an “utter...
-
Chris Brooker | 03/10/2017
Pharmacy’s 10 Rising Stars!
The AJP’s has announced its readers’ choice for the 10 early career pharmacists who are leading the profession...
-
Chris Brooker | 28/09/2017
Pharmacy’s privacy questioned
Concerns have been raised over privacy provisions in some pharmacies that administer vaccinations In its latest communique, the...
-
Chris Brooker | 18/09/2017
The search continues…
entries continue to roll in for our ‘Search for Australia’s Oldest Medicines’, co-run by AJP and the Return of...
-
Chris Brooker | 04/09/2017
King recommendations could jeopardise distribution
wholesale distribution model could fall over without sensible financial reforms, say industry bosses who dismiss King Review recommendations...